@2024 - All Right Reserved.
INDIANAPOLIS, May 8, 2020 /PRNewswire/ -- New36-week data showed higher investigational doses of Trulicity (3 mg and 4.5 mg) were well-tolerated and led to A1C reductions up to 1.9 percent and weight ...
In the AWARD-7 trial, patients who received Trulicity 0.75mg or 1.5mg in combination with mealtime insulin lispro achieved similar glycemic control with weight loss vs patients who received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback